BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26252635)

  • 1. IL-6 Inhibits the Targeted Modulation of PDCD4 by miR-21 in Prostate Cancer.
    Dong B; Shi Z; Wang J; Wu J; Yang Z; Fang K
    PLoS One; 2015; 10(8):e0134366. PubMed ID: 26252635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-21 increases the programmed cell death 4 gene-regulated cell proliferation in head and neck squamous carcinoma cell lines.
    Sun Z; Li S; Kaufmann AM; Albers AE
    Oncol Rep; 2014 Nov; 32(5):2283-9. PubMed ID: 25175929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in GAS5 affect the transformation from benign prostate proliferation to aggressive prostate cancer by affecting the transcription efficiency of GAS5.
    Zhu L; Zhu Q; Wen H; Huang X; Zheng G
    J Cell Physiol; 2019 Jun; 234(6):8928-8940. PubMed ID: 30317620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
    Li F; Gu C; Tian F; Jia Z; Meng Z; Ding Y; Yang J
    Oncol Rep; 2016 May; 35(5):2859-65. PubMed ID: 26986507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 stimulates gastric cancer growth and invasion by inhibiting the tumor suppressor effects of programmed cell death protein 4 and phosphatase and tensin homolog.
    Li L; Zhou L; Li Y; Lin S; Tomuleasa C
    J BUON; 2014; 19(1):228-36. PubMed ID: 24659669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
    Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
    J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of microRNA-21 in radiosensitivity in non-small cell lung cancer cells by targeting PDCD4 gene.
    Jiang LP; He CY; Zhu ZT
    Oncotarget; 2017 Apr; 8(14):23675-23689. PubMed ID: 28423589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis.
    Cha YJ; Lee JH; Han HH; Kim BG; Kang S; Choi YD; Cho NH
    Prostate; 2016 Jul; 76(10):937-47. PubMed ID: 27017949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. INSL3 in the benign hyperplastic and neoplastic human prostate gland.
    Klonisch T; Müller-Huesmann H; Riedel M; Kehlen A; Bialek J; Radestock Y; Holzhausen HJ; Steger K; Ludwig M; Weidner W; Hoang-Vu C; Hombach-Klonisch S
    Int J Oncol; 2005 Aug; 27(2):307-15. PubMed ID: 16010410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of microRNA-21 on the proliferation of human degenerated nucleus pulposus by targeting programmed cell death 4.
    Chen B; Huang SG; Ju L; Li M; Nie FF; Zhang Y; Zhang YH; Chen X; Gao F
    Braz J Med Biol Res; 2016 May; 49(6):. PubMed ID: 27240294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overexpression of miR-21 promotes proliferation and reduces apoptosis in non-small cell lung cancer].
    Lan H; Lin CY; Yuan HY; Xiong B
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):742-6. PubMed ID: 22335905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Essential role of NADPH oxidase-dependent reactive oxygen species generation in regulating microRNA-21 expression and function in prostate cancer.
    Jajoo S; Mukherjea D; Kaur T; Sheehan KE; Sheth S; Borse V; Rybak LP; Ramkumar V
    Antioxid Redox Signal; 2013 Dec; 19(16):1863-76. PubMed ID: 23682737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDCD4 Is an Androgen-Repressed Tumor Suppressor that Regulates Prostate Cancer Growth and Castration Resistance.
    Zennami K; Choi SM; Liao R; Li Y; Dinalankara W; Marchionni L; Rafiqi FH; Kurozumi A; Hatano K; Lupold SE
    Mol Cancer Res; 2019 Feb; 17(2):618-627. PubMed ID: 30518628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-26b inhibits autophagy by targeting ULK2 in prostate cancer cells.
    John Clotaire DZ; Zhang B; Wei N; Gao R; Zhao F; Wang Y; Lei M; Huang W
    Biochem Biophys Res Commun; 2016 Mar; 472(1):194-200. PubMed ID: 26920049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer.
    Motoyama K; Inoue H; Mimori K; Tanaka F; Kojima K; Uetake H; Sugihara K; Mori M
    Int J Oncol; 2010 May; 36(5):1089-95. PubMed ID: 20372781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
    Asangani IA; Rasheed SA; Nikolova DA; Leupold JH; Colburn NH; Post S; Allgayer H
    Oncogene; 2008 Apr; 27(15):2128-36. PubMed ID: 17968323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ars2 is overexpressed in human cholangiocarcinomas and its depletion increases PTEN and PDCD4 by decreasing microRNA-21.
    He Q; Cai L; Shuai L; Li D; Wang C; Liu Y; Li X; Li Z; Wang S
    Mol Carcinog; 2013 Apr; 52(4):286-96. PubMed ID: 22213145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of microRNA-21 via locked nucleic acid-anti-miR suppressed metastatic features of colorectal cancer cells through modulation of programmed cell death 4.
    Nedaeinia R; Sharifi M; Avan A; Kazemi M; Nabinejad A; Ferns GA; Ghayour-Mobarhan M; Salehi R
    Tumour Biol; 2017 Mar; 39(3):1010428317692261. PubMed ID: 28347230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma.
    Zhu Q; Wang Z; Hu Y; Li J; Li X; Zhou L; Huang Y
    Oncol Rep; 2012 May; 27(5):1660-8. PubMed ID: 22322403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.